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Purpose: Despite its clinical importance, adolescent subthreshold depression remains a largely 
neglected topic. The aims of this study were to accurately identify the natural course of depres-
sive symptoms and the risk for developing major depressive episode (MDE) in late adolescents 
with subthreshold depression over 1 year.
Patients and methods: One hundred and seventy-two participants 20 years of age (mean 
age: 18.32 years, standard deviation: 0.50), who did not meet the full criteria for an MDE, were 
selected from 2,494 screened freshmen based on the Beck Depression Inventory, 2nd edition 
(BDI-II). We conducted a cohort study of three groups (low-, middle-, and high-symptom 
groups) divided based on BDI-II scores, over a 1 year period with the use of bimonthly assess-
ments. Temporal changes of depressive symptoms were analyzed using linear mixed modeling 
and growth mixture modeling.
Results: First, we found that late adolescents with subthreshold depression (high depressive 
symptoms) were split between the increasing and decreasing depressive symptoms groups, 
whereas the majority of the less-symptoms group remained stable during 1 year. Second, in 
comparison with late adolescents with less depressive symptoms, those with subthreshold 
depression had an elevated risk of later depression.
Conclusion: Some late adolescents with subthreshold depression had increased depressive 
symptoms and developed an MDE during 1 year. Therefore, it is necessary for us to rigorously 
assess the changes in subthreshold depressive symptoms over time in late adolescents.
Keywords: adolescence, subthreshold depression, major depressive episode, university student, 
cohort study
Introduction
In recent years, there has been considerable interest in the clinical significance of 
subthreshold depression (ie, the presence of clinically relevant depressive symptoms 
that do not meet the full criteria of a major depressive episode [MDE]) in adolescence.1 
Subthreshold depressive symptoms among adolescents are highly prevalent and are a 
considerable health problem.2 Several studies suggest that childhood and adolescent 
subthreshold depression are associated with severe impairment3,4 and with the future risk 
of developing an MDE,5–7 which is similar to findings in adult populations.8,9 Although 
the participants were children and adolescents 18 years of age, a recent systematic 
review10 indicated that subthreshold depression and major depression are common con-
ditions with similar risk factor patterns. The clinical characteristics of both subthreshold 
depression and major depression are depressed mood and high psychiatric comorbidity 
with anxiety and conduct disorders. In addition, both subthreshold depression and 
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major depression have comparably poor outcomes, with 
increased psychiatric morbidity and health service use.10 
However, compared to the significant amount of research on 
major depression, little attention has been given to the issue 
of sustained subthreshold depression in adolescence.
The prevalence of subthreshold depression in adolescence 
peaks in the mid-teens and then reduces with age.2,6,11,12 In con-
trast, the prevalence of major depression increases linearly 
from the mid-teens to mid-twenties.2,6,13 It is reported that the 
transition from subthreshold depression to major depression 
occurs in late adolescence.2 Several researchers have observed 
that the prevalence of psychological distress is higher among 
students than among working nonstudent populations of the 
same sex and age.14–17 In Japan, it has been reported that the 
prevalence of depression was quite high in first-year univer-
sity students.18 Especially the first year in university student’s 
life is a period of vulnerability during which young students 
establish, test, and adjust to new psychological identities.19 
Thus, in late adolescence, it is necessary to rigorously analyze 
temporal changes in depressive symptoms during the first 
year of admission into the university.
Several studies have indicated that the persistence of 
adolescent depressive symptoms is predictive of subsequent 
mental health problems.20,21 In these studies, depressive 
symptoms were measured at several points in adolescence 
and young adulthood. Persistent adolescent depressive symp-
toms (high scores consistent across time points) were asso-
ciated with abnormal psychosocial and mental functioning 
in early adulthood, while episodic high scores (at only one 
time point in adolescence) were not.20 Although this research 
provides estimates of persistent depressive symptoms, the 
data sampling interval in these studies was every several 
years. It has been shown that repeated and more frequent 
assessments of the same individuals could overcome the 
potential biases of reminiscence over long periods and could 
more accurately identify the onset and natural course of the 
disorder throughout the developmental period.6
The aims of this study were to accurately identify 
the natural course of depressive symptoms and the risk 
for developing MDE in late adolescents with subthreshold 
depression over 1 year. In the present study, subthreshold 
depression was defined as the presence of any depressive 
symptoms, as measured by the Beck Depression Inventory, 
2nd edition (BDI-II), that do not meet the full criteria for 
an MDE. Therefore, we conducted a cohort study in three 
groups (low-, middle-, and high-symptom group) of first-year 
university students, divided based on BDI-II scores, to 
examine their detailed course of depressive symptoms and 
risk for developing an MDE over a 12-month period.
Methods
Participants
First-year undergraduate students were recruited from 
Hiroshima University in Japan. The inclusion criteria were 
1) age 18–19 years (at the time of entry into university), 2) not 
having an MDE during the previous 12 months, and 3) not 
currently taking psychotropic drugs or receiving psycho-
therapy for a mental health problem. The exclusion criteria 
were 1) a diagnosed lifetime history of bipolar disorder and 
2) having a serious physical illness.
Measures
The Japanese version of the BDi-ii
The original BDI-II, developed by Beck et al,22 is a widely 
used self-reported questionnaire that assesses the severity of 
depression. The BDI-II consists of 21 items rated on a four-
point scale ranging from 0 to 3. A high score indicates that 
depressive symptoms are severe. The validity and reliability 
of the Japanese version has been confirmed.23 A cutoff score 
of 18 in the BDI-II yielded a sensitivity of 94% and a specific-
ity of 92%, and a cutoff score of 10 yielded a sensitivity of 
100% and a specificity of 70%.24 Participants completed the 
BDI-II every 2 months (annual checkup, baseline assessment, 
2, 4, 6, 8, 10, and 12 months later).
composite international Diagnostic interview
The Composite International Diagnostic Interview (CIDI)25 
is a fully structured diagnostic interview that assesses mental 
disorders using the definitions and criteria of the Diagnostic 
and Statistical Manual of Mental Disorders, Fourth Edition. 
We used the computer-assisted personal interview version 
to assess mental state at baseline and at a 1-year follow-up. 
In the interview, we included the sections evaluating mood 
disorders and anxiety disorders (panic disorder, social phobia, 
agoraphobia, generalized anxiety disorder, and posttraumatic 
stress disorder). We used the Japanese version of the CIDI,26 
which was administered by trained interviewers who were 
psychiatrists or graduate clinical psychology students. The 
CIDI was conducted at baseline and 12 months later.
Procedure
The participants in this study were freshmen from Hiroshima 
University. The BDI-II is performed as part of an annual 
checkup for all freshmen. Most students complete it every 
year (with an average response rate of 99%). In this study, 
2,494 freshmen were screened using the BDI-II as part of 
the checkup, and 2,281 freshmen 20 years of age at the 
point of entry into university responded. In the present study, 
subthreshold depression was defined as the presence of any 
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depressive symptoms, as measured by the BDI-II, that do 
not meet the full criteria for an MDE. It has been shown 
that a cutoff score of 18 in the BDI-II yields a sensitivity 
of 94% and a specificity of 92% and that a cutoff score of 
10 yields a sensitivity of 100% and a specificity of 70%.24 
On the basis of a previous study,24 we created three groups 
using the BDI-II scores (the low-symptom group: BDI-II 
score 10, the middle-symptom group: BDI-II score =11–17, 
and the high-symptom group: BDI-II score 18). Participants 
were categorized into the symptom groups as follows: low-
symptom group (n=1,918), middle-symptom group (n=276), 
and high-symptom group (n=87). For the low- and middle-
symptom groups, we contacted randomly selected students 
by mail via the Hiroshima University information system. As 
there were only a few students in the high-symptom group, we 
contacted all students in this group. At this point of contact, 
we gave them a brief explanation of the study. Some students 
(low-symptom group: n=72, middle-symptom group: n=62, 
high-symptom group: n=68) who were interested in study 
participation were provided detailed information regarding 
this study. After obtaining consent, all potential participants 
(low-symptom group: n=68, middle-symptom group: n=57, 
high-symptom group: n=66) were assessed using the CIDI 
face-to-face by a trained interviewer. Then, the participants 
were selected according to the study’s inclusion and exclusion 
criteria of the CIDI. Follow-up was done every two months 
(2, 4, 6, 8, 10, and 12 months later), for one year, to assess 
depressive symptoms using the BDI-II. At the 12-month 
follow-up, all participants completed the CIDI.
The Ethics Committee of Hiroshima University approved 
the study and the study protocol, and written informed con-
sent was obtained from all participants.
Data analysis
We analyzed the data of 172 students who completed the 
BDI-II and CIDI at baseline and 12 months later. First, we 
calculated descriptive data and investigated the baseline 
differences in the demographic data using analysis of vari-
ance (ANOVA) and χ2 tests. A previous study has reported 
that BDI-II consists of two subscales (somatic–affective and 
cognitive).22,23 We examined whether there were significant 
differences in these two subscale scores within each group, 
and we also compared them between different groups. 
Second, we conducted linear mixed modeling with time 
and group as factors to examine differences in change over 
1 year. Thus, the predictors in the models were time, group, 
and time × group. We adopted the random intercepts and 
slope model with maximum likelihood estimation. The ran-
dom effects of this model were intercepts and slope of time. 
Third, we conducted Fisher’s exact test to examine differ-
ences in the incidence of MDE between the three groups. 
Subsequently, if there were significant differences in the 
results of the Fisher’s exact test, residual analysis between 
the three groups was conducted to explore them. Fourth, 
after we examined whether there were dispersions of slope 
in our participants, we conducted a growth mixture model-
ing (GMM) to identify subtypes of longitudinal trajectories 
in depressive symptoms. To examine model fit with latent 
trajectories, we used the Bayesian information criteria (BIC) 
and the entropy.27–29 Finally, we examined how many par-
ticipants from the BDI-II groups were present in different 
classes. Statistical analyses of ANOVA, χ2 tests, and Fisher’s 
exact test were done using SPSS version 22.0 (IBM Cor-
poration, Armonk, NY, USA) for Windows. Linear mixed 
modeling and GMM analyses were carried out using the 
R statistical computing environment (version 3.2.1; http://
www.R-project.org/), together with the LCMM package.30
Results
Participants
After obtaining written informed consent, a trained inter-
viewer conducted the CIDI face-to-face, and participants 
completed the scales. One participant in the middle-symptom 
group and 12 participants in the high-symptom group were 
excluded because they either met the criteria for major 
depression in the past year or had a lifetime history of bipolar 
disorder. Finally, 176 participants were selected based on 
the inclusion and exclusion criteria. The flow of participants 
is described in Figure 1. Sixty-six participants in the low-
symptom group, 56 participants in the middle-symptom 
group, and 54 participants in the high-symptom group met the 
eligibility criteria. Sixty-six freshmen in the low-symptom 
group (100%), 55 in the middle-symptom group (98.2%), 
and 51 in the high-symptom group (94.4%) completed the 
follow-up assessment 12 months later. One participant in the 
middle-symptom group and three participants in the high-
symptom group were excluded because they did not receive 
the assessments at the 12-month follow-up.
Basic demographic and clinical 
characteristics
Table 1 lists the demographic and clinical characteristics of 
the participants. We examined whether there were significant 
differences in age, gender distribution, and clinical charac-
teristics between the three groups by conducting ANOVA 
and χ2 tests. The age, gender distribution, history of major 
depression, and comorbidity of anxiety disorders did not 
differ significantly between the three groups. One-way 
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Figure 1 Participant flow.
Abbreviations: BDi-ii, Beck Depression inventory, 2nd edition; MDe, major depressive episode; ciDi, composite international Diagnostic interview.
Table 1 Basic demographic and clinical characteristics of participants
The low-symptom 
group, N=66
The middle-symptom 
group, N=55
The high-symptom 
group, N=51
P-value
Male/female 37/29 32/23 36/15 0.24
Mean age, years 18.4 (0.5) 18.4 (0.5) 18.2 (0.4) 0.24
BDi-ii score at medical examination before the university admission 3.5 (3.2)a 13.2 (2.0)b 21.9 (4.0)c 0.01
BDi-ii score in baseline ciDi 4.6 (4.5)a 8.7 (4.3)b 12.8 (5.8)c 0.01
somatic-affective of BDi-ii score in baseline ciDi 2.5 (2.2)a 4.7 (2.6)b 6.8 (3.6)c 0.01
cognitive of BDi-ii score in baseline ciDi 2.0 (3.0)a 4.1 (2.9)b 6.0 (3.4)c 0.01
lifetime diagnosis of major depressive disorder
Yes/no 0/66 1/54 2/49 0.20
lifetime diagnosis of anxiety disorder
Yes/no 2/64 7/48 6/45 0.97
anxiety disorder diagnosis in past year
Yes/no 2/64 6/49 6/45 0.14
Notes: Values in parentheses represent standard deviation. There are significant differences between different shoulder alphabet (a, b, and c) (P0.05).
Abbreviations: ciDi, composite international Diagnostic interview; BDi-ii, Beck Depression inventory-ii.
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ANOVAs yielded significant differences between the three 
groups for BDI-II scores. We then conducted multiple com-
parisons for each of the scales, which yielded significant 
differences between the three groups for BDI-II scores. Next, 
we examined whether there were significant differences in 
the two subscales for the three groups. The results of an 
ANOVA indicated that there were no significant differences 
in the two subscales within each group. We also conducted 
an ANOVA to examine significant difference in the two 
BDI-II subscales between the three groups. The results of 
the ANOVAs showed that there were significant differences 
in BDI-II scores between the three groups.
average scores of depressive symptoms 
in follow-up surveys
We conducted linear mixed modeling to examine signifi-
cant differences between the seven time points the BDI-II 
was administered (Figure 2). There was no significant 
interaction between all groups, but the main effects of the 
middle-symptom group (estimate =5.14, standard error 
[SE] =0.86, t-value =5.98, P0.01) and the high-symptom 
group (estimate =8.89, SE =0.88, t-value =10.14, P0.01) 
were significant. The multiple comparisons revealed sig-
nificant differences between the three groups (mean of the 
low-symptom group =4.81, mean of the middle-symptom 
group =9.95, and mean of the high-symptom group =13.69, 
P0.01), but there was no main effect of time (esti-
mate =-0.12, SE =0.11, t-value =-1.06, P=0.29). Next, we 
examined whether there were statistical dispersions of the 
slope within the group. The results indicated that the disper-
sions of the slope were large (χ2 =34.7, degrees of freedom 
[df] =2, P0.01).
individual trajectories of depressive 
symptoms
The linear mixed modeling was inappropriate for analyzing 
longitudinal data, if the variance of the slope in longitu-
dinal data was large.31 Result of linear mixed modeling 
indicated that dispersions of the slope in our participants 
were large (χ2 =34.7, df =2, P0.01). Therefore, to identify 
particular change of depressive symptoms, we used a GMM 
to analyze the data. The results indicate that six classes 
were estimated. To identify the number of latent trajec-
tory classes, we used the BIC and the entropy. The results 
revealed that the BIC scores were lowest for the three-class 
solution (one-class =7,028.59, two-class =6,967.61, three-
class =6,943.98, four-class =6,972.57, five-class =6,961.77, 
six-class =6,986.12). Based on a previous study,32 we also 
calculated the entropy. The entropy score for the three-class 
solution was 0.81. Judging from fit indexes of BIC and 
entropy, we adopted three classes. The average latent class 
probabilities for most likely latent class membership by latent 
class for the three-class model was very good (Class 1 =0.94, 
Class 2 =0.91, and Class 3 =0.90). Figure 3 displays the 
results of the GMM. We named each class as follows: Class 1 
was the stable group, Class 2 was the decreasing group, and 
Class 3 was the increasing group. The parameter estimates for 
the model are provided in Table 2. There was no significant 
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Figure 2 average BDi-ii scores in follow-up surveys. average BDi-ii scores among the three groups over 12-month follow-up.
Note: The linear mixed modeling was conducted to examine differences in BDi-ii scores between the seven time points.
Abbreviation: BDi-ii, Beck Depression inventory, 2nd edition.
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change in depressive symptoms in the stable group (n=65). 
The stable group included 63 participants from the low-
symptom group and 2 participants from the middle-symptom 
group. The decreasing group (n=81) demonstrated a signifi-
cant decrease in depressive symptoms during the 12 months 
(P0.01). The decreasing group included 3 participants from 
the low-symptom group, 49 participants from the middle-
symptom group, and 29 participants from the high-symptom 
group. The increasing group (n=26) revealed a significant 
increase in depressive symptoms during the 12 months 
(P0.05). The increasing group included 4 participants 
from the middle-symptom group and 22 participants from 
the high-symptom group.
group risk of developing an MDe during 
the 12 months
Three students in the high-symptom group developed an 
MDE by the 12-month follow-up, whereas no one in the 
low- and middle-symptom groups did. We conducted 
Fisher’s test to examine differences in the incidence of MDE 
among the three groups, and found significant differences 
between the three groups (χ2(2) =4.85, P0.05). Addition-
ally, we conducted residual analysis among the three groups. 
Results revealed a significant difference in the incidence 
of MDE between the high-symptom group and the other 
groups (P0.05).
Discussion
To the best of our knowledge, the present study is the first 
to rigorously assess depressive symptoms (low-symptom 
group, middle-symptom group, and high-symptom group) 
in late adolescence over a 1-year period with the use of 
bimonthly assessments to improve the accuracy of reported 
symptoms and the onset of depression. Two major findings 
emerged from this longitudinal study. First, we found that late 
adolescents with high depressive symptoms (subthreshold 
depression) were split between the increasing and decreas-
ing depressive symptoms groups, whereas the majority of 
the low and middle symptoms group remained stable over 
a 12-month period. Second, in comparison with late adoles-
cents with low and middle depressive symptoms, those with 
high symptoms (subthreshold depression) had an elevated 
risk of later depression.
Only 29% and 39% of the participants who were 
contacted, respectively, from low- and middle-symptom 
groups participated in the study, whereas 78% of those in 
the high-symptom group participated. It has been reported 
that the severity of depression is the most important predic-
tor of using university psychiatric services, and therefore, 
highly depressed students might have searched and accessed 
psychiatric services more than other students,33 which might 
have increased the participation rate of students with high 
depressive symptoms compared to students with low or 
middle depressive symptoms.
The present longitudinal research focused on the 
symptomatic changes of subthreshold depression in late 
adolescents. Based on the result of linear mixed model-
ing, the BDI-II mean scores of the high-symptom group 
remained high throughout the year. However, the GMM 
results, which take into account individual differences, 
indicated that half of the participants in the high-symptom 
group showed an increase in depressive symptoms during 
the 12 months, whereas other participants experienced 
a decrease in symptoms. Thus, it seems that half of the 
participants in the high-symptom group were not at risk 
for developing an MDE. On the contrary, from results of 
linear mixed modeling and GMM, both individual and 





      7LPH
%',
,,
7KHLQFUHDVLQJJURXSFODVV
7KHGHFUHDVLQJJURXSFODVV
7KHVWDEOHJURXSFODVV
Figure 3 individual trajectories of depressive symptoms. This represents the results 
of gMM over the 12 months.
Abbreviations: gMM, growth mixture modeling; BDi-ii, Beck Depression inventory, 
2nd edition.
Table 2 estimate for the three-class model
Estimated mean SE P-value
The stable group
intercept 4.07 0.61 0.00
slope -0.07 0.11 0.52
The decreasing group
intercept 11.14 0.68 0.00
slope -0.56 0.11 0.00
The increasing group
intercept 14.93 1.04 0.00
slope 0.51 0.21 0.02
Abbreviation: se, standard error.
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mean scores of the BDI-II scores in the low-symptom group 
remained stable in low depressive symptoms over the year. 
Although the middle-symptom group mean scores did not 
change over the year from results of linear mixed modeling, 
most participants in this group showed a decrease in the 
depressive symptoms over the 12 months from the result 
of GMM. Therefore, the middle-symptom group may be 
classified as low-risk.
In addition, our data revealed that subthreshold depression 
(high depressive symptoms) might increase the likelihood of 
developing an MDE over time. The number of participants 
meeting the criteria for MDE during the year was only 3 of 
172 students; however, it was noted that all were from the high-
symptom group and had subthreshold depression. In the pres-
ent study, three participants in the high-symptom group (n=51) 
developed an MDE. Therefore, the 1-year incidence of MDE 
in the high-symptom group was 5.8%. In a longitudinal study, 
Klein et al34 tested whether subthreshold depression among 
youth escalates or predicts the onset of full-syndrome depres-
sive disorder. Among those adolescents (aged 14–18 years) 
with a history of subthreshold depressive disorder at baseline, 
11.0% escalated to a full-syndrome depressive disorder dur-
ing the year.34 Fergusson et al5 also showed that subthreshold 
depression in late adolescence (ages 17–18 years) increased 
the risk of an MDE (27.4%) at age 18–21 years. The rate of 
an MDE development in our cohort is somewhat lower than 
reported in other studies,5,6,34 which might reflect the lower 
prevalence of mental disorders in Japan compared to Western 
countries.26,35–38 Moreover, an alternative explanation for the 
low prevalence rate may be the timing of assessments in this 
study. Since the first assessment took place during a very 
stressful time period (admission), the prevalence rates at 
baseline may not be comparable to other studies.
It is important to note some limitations of the current 
study. First, although there were significant differences in 
the incidence of MDE between the three groups at the 1-year 
follow-up, the length of follow-up (12 months) was relatively 
short. It is necessary to conduct a long-term follow-up study, 
because only three participants developed an MDE, whereas 
half of the participants showed an increase in depressive 
symptoms in the high-symptom group. Second, our results 
showed that depressive symptoms were the highest at the 
checkup before university admission and had reduced when 
entering the follow-up study. A possible explanation for the 
decrease in symptoms is that the timing of the assessments 
contributed to this effect. For example, at the baseline mea-
surement, late adolescents were not yet free from a highly 
stressful situation with regard to entrance examinations and 
were uneasy about the entrance into the university, which 
is a major transition point. As the adolescents acclimated 
to university, their stress and depression levels may have 
decreased by 2 months later. However, the depression levels 
in all the three groups were characterized by, on average, 
a relatively stable course after the first 2 months. Third, par-
ticipants in this study were recruited from only one specific 
university and enrollment in a single year. The homogeneity 
of the specific sample may limit the generalizability of our 
results to community or clinical populations. Future studies 
should examine similar hypotheses among adolescents in 
other Japanese provinces to determine if the current findings 
can be replicated and, consequently, be generalized. Finally, 
we have not excluded the possibility that the high-symptom 
group might be characterized by particular personal features. 
However, personal features of subjects were not examined 
in this study. Therefore, it would be necessary to investigate 
personal features of subjects in future studies.
Conclusion
Despite its clinical importance, adolescent subthreshold 
depression remains a largely neglected topic.2 Whereas the 
majority of the less symptoms group remains stable over time, 
some late adolescents with subthreshold depression show an 
increase in depressive symptoms and develop an MDE during 
1 year. Therefore, it is necessary for us to rigorously assess 
the changes in subthreshold depressive symptoms over time 
in the late adolescents.
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